BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Banerjee S, Yadav S, Banerjee S, Fakayode SO, Parvathareddy J, Reichard W, Surendranathan S, Mahmud F, Whatcott R, Thammathong J, Meibohm B, Miller DD, Jonsson CB, Dubey KD. Drug Repurposing to Identify Nilotinib as a Potential SARS-CoV-2 Main Protease Inhibitor: Insights from a Computational and In Vitro Study. J Chem Inf Model 2021;61:5469-83. [PMID: 34666487 DOI: 10.1021/acs.jcim.1c00524] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Islam MA, Kibria MK, Hossen MB, Reza MS, Tasmia SA, Tuly KF, Mosharof MP, Kabir SR, Kabir MH, Mollah MNH. Bioinformatics-based investigation on the genetic influence between SARS-CoV-2 infections and idiopathic pulmonary fibrosis (IPF) diseases, and drug repurposing. Sci Rep 2023;13:4685. [PMID: 36949176 DOI: 10.1038/s41598-023-31276-6] [Reference Citation Analysis]
2 Rizzi M, Tonello S, D'Onghia D, Sainaghi PP. Gas6/TAM Axis Involvement in Modulating Inflammation and Fibrosis in COVID-19 Patients. Int J Mol Sci 2023;24. [PMID: 36674471 DOI: 10.3390/ijms24020951] [Reference Citation Analysis]
3 Sarker B, Rahaman MM, Islam MA, Alamin MH, Husain MM, Ferdousi F, Ahsan MA, Mollah MNH. Identification of host genomic biomarkers from multiple transcriptomics datasets for diagnosis and therapies of SARS-CoV-2 infections. PLoS One 2023;18:e0281981. [PMID: 36913345 DOI: 10.1371/journal.pone.0281981] [Reference Citation Analysis]
4 Sun Y, Zhao B, Wang Y, Chen Z, Zhang H, Qu L, Zhao Y, Song J. Optimization of potential non-covalent inhibitors for the SARS-CoV-2 main protease inspected by a descriptor of the subpocket occupancy. Phys Chem Chem Phys 2022. [PMID: 36468652 DOI: 10.1039/d2cp03681a] [Reference Citation Analysis]
5 Lei S, Chen X, Wu J, Duan X, Men K. Small molecules in the treatment of COVID-19. Signal Transduct Target Ther 2022;7:387. [PMID: 36464706 DOI: 10.1038/s41392-022-01249-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Hu H, Mady Traore MD, Li R, Yuan H, He M, Wen B, Gao W, Jonsson CB, Fitzpatrick EA, Sun D. Optimization of the Prodrug Moiety of Remdesivir to Improve Lung Exposure/Selectivity and Enhance Anti-SARS-CoV-2 Activity. J Med Chem 2022. [PMID: 36070561 DOI: 10.1021/acs.jmedchem.2c00758] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Banerjee S, Lee S, Norman DD, Tigyi GJ. Designing Dual Inhibitors of Autotaxin-LPAR GPCR Axis. Molecules 2022;27:5487. [DOI: 10.3390/molecules27175487] [Reference Citation Analysis]
8 Herrera-rodulfo A, Andrade-medina M, Carrillo-tripp M. Repurposing Drugs as Potential Therapeutics for the SARS-Cov-2 Viral Infection: Automatizing a Blind Molecular Docking High-throughput Pipeline. Biomedical Engineering 2022. [DOI: 10.5772/intechopen.105792] [Reference Citation Analysis]
9 Rieder AS, Deniz BF, Netto CA, Wyse ATS. A Review of In Silico Research, SARS-CoV-2, and Neurodegeneration: Focus on Papain-Like Protease. Neurotox Res 2022. [PMID: 35917086 DOI: 10.1007/s12640-022-00542-2] [Reference Citation Analysis]
10 Hashemzadeh H, Iranshahy M, Iranshahi M, Raissi H. In silico exploration of disulfide derivatives of Ferula foetida oleo-gum (Covexir®) as promising therapeutics against SARS-CoV-2. Comput Biol Med 2022;146:105566. [PMID: 35598351 DOI: 10.1016/j.compbiomed.2022.105566] [Reference Citation Analysis]
11 Kandeel M, Kim J, Fayez M, Kitade Y, Kwon HJ. Antiviral drug discovery by targeting the SARS-CoV-2 polyprotein processing by inhibition of the main protease. PeerJ 2022;10:e12929. [PMID: 35186496 DOI: 10.7717/peerj.12929] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Hernández González JE, Eberle RJ, Willbold D, Coronado MA. A Computer-Aided Approach for the Discovery of D-Peptides as Inhibitors of SARS-CoV-2 Main Protease. Front Mol Biosci 2022;8:816166. [DOI: 10.3389/fmolb.2021.816166] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]